C/ BASE NO CPA 2024_900 - LAMIVUDINA 300 MG + DOLUTEGRAVIR 50 MG COMP
TED · 569185-2026Award noticeawardedNo deadline given
Who already wins at this buyer
Firms with recorded awards from Unidade Local de Saúde de Coimbra, EPE in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| Brainlab Sales GmbH | 2 | €2,619,329 | 2026-10-08 |
| Cencora 3PL Portugal, S.A. | 2 | €1,435,097 | 2026-10-28 |
| ROCHE FARMACÊUTICA QUÍMICA, LDA. | 2 | €1,240,039 | 2026-10-29 |
| Cencora 3Pl Portugal, S.A. | 2 | €823,396 | 2026-10-27 |
| Roche Farmacêutica Química, Lda. | 2 | — | 2026-10-08 |
Full buyer profile: what Unidade Local de Saúde de Coimbra, EPE buys and who wins it →
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
Aquisição do medicamento LAMIVUDINA 300 MG + DOLUTEGRAVIR 50 MG COMP
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-07-28 | 2024/0900 - LAMIVUDINA + DOLUTEGRAVIR [300 MG + 50 MG COMP] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 96% |
| 2026-08-04 | 2024/0900 - DOLUTEGRAVIR + ABACAVIR + LAMIVUDINA [50 MG + 600 MG + 300 MG CÁP/COMP] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 96% |
| 2026-10-27 | L1061 - LAMIVUDINA + DOLUTEGRAVIR [300 MG + 50 MG COMP] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 95% |
| 2026-10-26 | C/ BASE NO CPA 2026_6 - CABOZANTINIB 20 MG COMP + TEPOTINIB 225 MG COMP | Unidade Local de Saúde de Coimbra, EPE PT | 94% |
| 2026-06-30 | 2024/0900 - DOLUTEGRAVIR + RILPIVIRINA [50 MG + 25 MG CÁP/ COMP] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 94% |
| 2026-10-28 | C/ BASE NO CPA 2026_6 | Unidade Local de Saúde de Coimbra, EPE PT | 93% |